We serve Chemical Name:Methyl 2-(benzylamino)acetate CAS:17136-35-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Methyl 2-(benzylamino)acetate
CAS.NO:17136-35-5
Synonyms:methyl 2-(benzylamino)acetate
Molecular Formula:C10H14ClNO2
Molecular Weight:215.67700
HS Code:2922499990
Physical and Chemical Properties:
Melting point:N/A
Boiling point:259.6ºC at 760mmHg
Density:1.069g/cm3
Index of Refraction:1.513
PSA:38.33000
Exact Mass:215.07100
LogP:2.14210
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like methyl 2-(benzylamino)acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,methyl 2-(benzylamino)acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,methyl 2-(benzylamino)acetate Use and application,methyl 2-(benzylamino)acetate technical grade,usp/ep/jp grade.
Related News: Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients. Methyl 2-(benzylamino)acetate manufacturer The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said. Methyl 2-(benzylamino)acetate supplier In approving the first new Alzheimer’s drug in nearly 20 years, the U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows new therapies onto the market without strong evidence that they work, regulatory and scientific experts say. Methyl 2-(benzylamino)acetate vendor Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China. Methyl 2-(benzylamino)acetate factory Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.
